WO1994001548A3 - Fragments d'acide nucleiques humains isoles du cerveau, des tissus surrenaux, du placenta ou de la moelle osseuse - Google Patents

Fragments d'acide nucleiques humains isoles du cerveau, des tissus surrenaux, du placenta ou de la moelle osseuse Download PDF

Info

Publication number
WO1994001548A3
WO1994001548A3 PCT/GB1993/001467 GB9301467W WO9401548A3 WO 1994001548 A3 WO1994001548 A3 WO 1994001548A3 GB 9301467 W GB9301467 W GB 9301467W WO 9401548 A3 WO9401548 A3 WO 9401548A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
placenta
isolated
acid fragments
human nucleic
Prior art date
Application number
PCT/GB1993/001467
Other languages
English (en)
Other versions
WO1994001548A2 (fr
Inventor
David Ross Sibson
Jacqueline Gross
Kathryn Mary Hadfield
David Howells
Michael Starkey
Maria Kelly
Diana Shaw
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Priority to AU45121/93A priority Critical patent/AU4512193A/en
Publication of WO1994001548A2 publication Critical patent/WO1994001548A2/fr
Publication of WO1994001548A3 publication Critical patent/WO1994001548A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne un acide nucléique codant pour un produit génique, ou une de ses parties, et comprenant l'une ou l'autre des séquences suivantes: (a) une séquence sélectionnée dans l'identification des séquences 1 à 1193 selon la liste des séquences annexée; (b) une variation allélique d'une séquence telle que définie dans (a); ou (c) une séquence complémentaire de (a) ou (b). L'invention concerne aussi les utilisations de tels fragments et les produits géniques correspondants.
PCT/GB1993/001467 1992-07-13 1993-07-13 Fragments d'acide nucleiques humains isoles du cerveau, des tissus surrenaux, du placenta ou de la moelle osseuse WO1994001548A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU45121/93A AU4512193A (en) 1992-07-13 1993-07-13 Human nucleic acid fragments, isolated from brain adrenal tissue, placenta or bone narrow

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929214857A GB9214857D0 (en) 1992-07-13 1992-07-13 Human nucleic acid fragments and their use
GB9214857.6 1992-07-13

Publications (2)

Publication Number Publication Date
WO1994001548A2 WO1994001548A2 (fr) 1994-01-20
WO1994001548A3 true WO1994001548A3 (fr) 1994-03-31

Family

ID=10718624

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1993/001467 WO1994001548A2 (fr) 1992-07-13 1993-07-13 Fragments d'acide nucleiques humains isoles du cerveau, des tissus surrenaux, du placenta ou de la moelle osseuse

Country Status (4)

Country Link
EP (1) EP0587279A1 (fr)
AU (1) AU4512193A (fr)
GB (1) GB9214857D0 (fr)
WO (1) WO1994001548A2 (fr)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965362A (en) 1992-03-04 1999-10-12 The Regents Of The University Of California Comparative genomic hybridization (CGH)
GB9214873D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Process for categorising nucleotide sequence populations
US5891633A (en) * 1994-06-16 1999-04-06 The United States Of America As Represented By The Department Of Health And Human Services Defects in drug metabolism
AU2860295A (en) * 1994-06-16 1996-01-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Defects in drug metabolism
US5847099A (en) * 1994-10-19 1998-12-08 Genetics Institute, Inc. TNF receptor death domain ligand proteins
US5852173A (en) * 1994-10-19 1998-12-22 Genetics Institute, Inc. TNF receptor death ligand proteins and inhibitors of ligand binding
US5712381A (en) * 1994-10-19 1998-01-27 Genetics Institute, Inc. MADD, a TNF receptor death domain ligand protein
US5849501A (en) * 1994-10-19 1998-12-15 Genetics Institute, Inc. TNF receptor death domain ligand proteins and method to identify inhibitors of ligand binding
US6468765B1 (en) * 1995-04-21 2002-10-22 Human Genome Sciences, Inc. Selected Haemophilus influenzae Rd polynucleotides and polypeptides
DE69636737T2 (de) * 1995-06-20 2007-10-18 Roche Diagnostics Gmbh Neues immunoregulatorisches protein lst-1
US5965388A (en) * 1996-07-09 1999-10-12 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
EP0845034B1 (fr) * 1995-08-15 2003-03-05 Euroscreen S.A. peptide presentant des proprietes pronociceptives
US7083932B1 (en) 1995-08-15 2006-08-01 Euroscreen, S.A. Nucleic acid molecules encoding peptides having pronociceptive properties
US6054289A (en) 1995-08-30 2000-04-25 Human Genome Sciences, Inc. Polynucleotides encoding human ADA2
US6329169B1 (en) 1995-09-29 2001-12-11 Human Genome Sciences, Inc. Nucleic acid molecules encoding cytostatin II
US7455964B1 (en) 1996-07-15 2008-11-25 The Hospital For Sick Children Genes from the 20q13 amplicon and their uses
US7049424B2 (en) 1996-07-15 2006-05-23 The Regents Of The University Of California Genes from the 20Q13 amplicon and their uses
US5804412A (en) * 1996-04-01 1998-09-08 The Regents Of The University Of California Nucleic acids encoding sorting nexins and methods of using same
WO1997038003A1 (fr) * 1996-04-11 1997-10-16 Human Genome Sciences, Inc. Proteine humaine specifique a l'hematopoïese
US6280739B1 (en) 1996-04-18 2001-08-28 Genetics Institute, Inc. Method of inhibiting angiogenesis using secreted proteins
CA2253259A1 (fr) * 1996-04-30 1997-11-06 Bundesrepublik Deutschland Vertreten Durch Den Bundesminister Fur Gesundheit Polypeptides traites a activite d'il-16, leur procede de preparation et leur utilisation
AU3602097A (en) * 1996-07-15 1998-02-09 Regents Of The University Of California, The Genes from 20q13 amplicon and their uses
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US6455040B1 (en) 1997-01-14 2002-09-24 Human Genome Sciences, Inc. Tumor necrosis factor receptor 5
AU6238698A (en) * 1997-01-14 1998-08-03 Human Genome Sciences, Inc. Tumor necrosis factor receptor 5
US6008018A (en) * 1997-02-19 1999-12-28 Human Genome Sciences, Inc. ELL2, a new member of an ELL family of RNA polymerase II elongation factors
DE69839582D1 (de) 1997-02-27 2008-07-17 Ono Pharmaceutical Co Neues polypeptid, dafür kodierende dna und deren verwendungen
CA2285040C (fr) * 1997-03-17 2009-01-27 Human Genome Sciences, Inc. Recepteur 5 contenant un domaine de mort
US6872568B1 (en) 1997-03-17 2005-03-29 Human Genome Sciences, Inc. Death domain containing receptor 5 antibodies
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US5919657A (en) * 1997-04-09 1999-07-06 Incyte Pharmaceuticals, Inc. Nucleic acids encoding human thioredoxin protein; related reagents
US6956108B2 (en) 1997-06-16 2005-10-18 Genentech, Inc. PRO1184 antibodies
US5891674A (en) * 1997-06-19 1999-04-06 Incyte Pharmaceuticals, Inc. Insulin receptor tyrosine kinase substrate
WO1999000405A1 (fr) * 1997-06-30 1999-01-07 Genetics Institute, Inc. Proteines secretees
AU8284498A (en) * 1997-07-02 1999-01-25 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
US6416973B1 (en) * 1997-08-01 2002-07-09 Schering Corporation Nucleic acids encoding mammalian cell membrane protein MDL-1
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
WO1999009061A1 (fr) * 1997-08-21 1999-02-25 Genetics Institute, Inc. Proteines secretees
US20030044839A1 (en) * 1997-09-17 2003-03-06 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7169906B2 (en) 1997-09-17 2007-01-30 Genentech, Inc. PRO211 polypeptides
US6974689B1 (en) 1997-09-18 2005-12-13 Genentech, Inc. Nucleic acid encoding PRO211 polypeptides
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
US6455283B1 (en) 1998-03-17 2002-09-24 Genentech, Inc. Nucleic acids encoding vascular endothelial cell growth factor-E (VEGF-E)
AU1101199A (en) * 1997-10-18 1999-05-10 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
US5891719A (en) 1997-11-16 1999-04-06 Tularik Inc. IKAP nucleic acids
US6297367B1 (en) * 1997-12-30 2001-10-02 Chiron Corporation Polynucleotide encoding TNFL1
US7012134B2 (en) 1998-01-26 2006-03-14 Human Genome Sciences, Inc. Dendritic enriched secreted lymphocyte activation molecule
US6620912B2 (en) 1998-01-26 2003-09-16 Human Genome Sciences, Inc. Dendritic enriched secreted lymphocyte activation molecule
US6706869B1 (en) * 1998-02-11 2004-03-16 Wyeth Map kinase phosphatases and polynucleotides encoding them
US6451977B1 (en) 1998-02-26 2002-09-17 Genentech, Inc. Fused polypeptides
EP1064302A1 (fr) * 1998-03-20 2001-01-03 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
CA2328496C (fr) 1998-05-15 2016-01-05 Genentech, Inc. Polypeptides homologues de il-17 et utilisations therapeutiques de ceux-ci
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
US6262333B1 (en) * 1998-06-10 2001-07-17 Bayer Corporation Human genes and gene expression products
CA2331386A1 (fr) 1998-06-26 2000-01-06 Incyte Pharmaceuticals, Inc. Proteines contenant un peptide signal humain
US6395877B1 (en) * 1998-06-30 2002-05-28 Millennium Pharmaceuticals, Inc. 14273 receptor, a novel G-protein coupled receptor
WO2000000611A2 (fr) 1998-06-30 2000-01-06 Millennium Pharmaceuticals, Inc. Recepteur 14273, recepteur couple a une proteine g
US6262228B1 (en) * 1998-08-17 2001-07-17 Tularik Inc. IRAK3 polypeptides and methods
AU6020599A (en) * 1998-08-25 2000-03-14 Incyte Pharmaceuticals, Inc. Cell surface immunomodulators
CN1317046A (zh) * 1998-09-03 2001-10-10 旭化成株式会社 新型受体蛋白及应用其的炎症疾病诊断方法
US6867017B1 (en) * 1998-10-23 2005-03-15 The United States Of America As Represented By The Department Of Health And Human Services ATP-binding transporter (ABC7) and methods for detection of anemia and ataxia
AU2021000A (en) 1998-11-03 2000-05-22 Penn State Research Foundation, The Novel nucleic acid molecules encoding opioid growth factor receptors
DE19855013C2 (de) * 1998-11-20 2001-09-13 Schering Ag Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element
KR20010090879A (ko) 1998-12-08 2001-10-19 추후제출 대장균주 오157:에이치7을 타 균주와 구별하는 다형성유전자좌
US6794161B1 (en) 1999-01-26 2004-09-21 Neurosearch A/S Potassium channels and genes encoding these potassium channels
US7083793B2 (en) 1999-02-26 2006-08-01 Millennium Pharmaceuticals, Inc. Tango 243 polypeptides and uses thereof
DE60013586T2 (de) * 1999-04-02 2005-02-03 Hisamitsu Pharmaceutical Co., Inc., Tosu Genexpressions-basensequenzen zur therapeutischen anwendung und heilmittel zur gentherapie
US6939545B2 (en) 1999-04-28 2005-09-06 Genetics Institute, Llc Composition and method for treating inflammatory disorders
US7307161B1 (en) 1999-04-28 2007-12-11 Genetics Institute, Llc Human Gil-19/AE289 polynucleotides
US6348192B1 (en) * 1999-05-11 2002-02-19 Bayer Corporation Interleukin-2 mutein expressed from mammalian cells
CN1244584A (zh) * 1999-05-14 2000-02-16 北京医科大学 具有免疫细胞趋化和造血刺激活性的趋化因子
US6428982B1 (en) * 1999-06-07 2002-08-06 Smithkline Beecham Corporation Polynucleotides encoding mouse urotensin-II Receptor (UTB-R)
JP2003502053A (ja) * 1999-06-11 2003-01-21 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４９個のヒト分泌タンパク質
WO2001004141A2 (fr) * 1999-07-12 2001-01-18 Merck Patent Gmbh Seripancrine
WO2001009166A1 (fr) * 1999-07-29 2001-02-08 Smithkline Beecham Corporation Utilisation d'octoray en tant que recepteur couple a la proteine g
US7148330B2 (en) 1999-07-30 2006-12-12 Schering Corporation Binding compounds for IL-27
JP2003506042A (ja) 1999-08-03 2003-02-18 ミレニアム ファーマシューティカルズ インク． セクレチン様ファミリーの新規ｇｐｃｒ様分子１５５７１及びその使用
WO2001016159A1 (fr) * 1999-08-27 2001-03-08 Smithkline Beecham Corporation Gpcr, ant
US6562591B1 (en) * 1999-10-21 2003-05-13 Rigel Pharmaceuticals, Inc. Germinal center kinase cell cycle proteins, compositions and methods of use
US7329728B1 (en) * 1999-10-25 2008-02-12 The Scripps Research Institute Ligand activated transcriptional regulator proteins
WO2001036479A1 (fr) * 1999-11-16 2001-05-25 Merck & Co., Inc. Recepteur couple a la proteine g
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US7514239B2 (en) 2000-03-28 2009-04-07 Amgen Inc. Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
US6740495B1 (en) 2000-04-03 2004-05-25 Rigel Pharmaceuticals, Inc. Ubiquitin ligase assay
US6979551B2 (en) 2000-04-03 2005-12-27 Rigel Pharmaceuticals, Inc. Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
US6600018B1 (en) 2000-04-10 2003-07-29 The United States Of America As Represented By The Department Of Health And Human Services Secreted frizzled related protein, sFRP, fragments and methods of use thereof
CA2410024A1 (fr) * 2000-04-25 2001-11-01 The Board Of Regents Of The University Oklahoma Identification et utilisations d'un recepteur de hyaluronan
US6623941B1 (en) * 2000-05-05 2003-09-23 Human Genome Sciences, Inc. Nucleic acids encoding human tumor necrosis factor TR20
AU6065901A (en) * 2000-05-31 2001-12-11 Nippon Zenyaku Kogyo Co Ltd Feline hepatocyte growth factor
US7442765B2 (en) * 2000-08-24 2008-10-28 Genentech, Inc. Secreted transmembrane polypeptides and nucleic acids encoding the same
US7268223B2 (en) 2000-09-22 2007-09-11 Wyeth Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
US7094570B2 (en) 2003-03-11 2006-08-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
AU2002224379A1 (en) * 2000-10-13 2002-04-22 Arbor Vita Corporation Clasp-2 transmembrane proteins
US7638604B2 (en) 2001-02-23 2009-12-29 Genetics Institute, Llc Monoclonal antibodies against interleukin-22
JP4309758B2 (ja) 2001-05-25 2009-08-05 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド Ｔｒａｉｌレセプターに免疫特異的に結合する抗体
EP1588139A4 (fr) 2001-05-31 2006-10-04 Merck & Co Inc Recepteur de type 2 a hormone de concentration de melanine de singe rhesus, chien et furet
CN1431306A (zh) * 2002-01-11 2003-07-23 复旦大学 人类肝癌衍生生长因子5、其编码序列、制法及用途
FR2836687A1 (fr) 2002-03-04 2003-09-05 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
EP1497306A4 (fr) * 2002-04-25 2006-01-04 Cornell Res Foundation Inc Molecules d'acides nucleiques a epissage alternatif
JP2006519582A (ja) * 2002-09-26 2006-08-31 ジェネンテック・インコーポレーテッド 乾癬の治療のための新規組成物と方法
WO2005005597A2 (fr) * 2003-06-09 2005-01-20 Five Prime Therapeutics, Inc. Nouveaux polypeptides de souris codes par des polynucleotides et leurs procedes d'utilisation
US7435808B2 (en) * 2003-06-25 2008-10-14 Bristol-Myers Squibb Company Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
US7795404B1 (en) * 2003-08-08 2010-09-14 Five Prime Therapeutics, Inc. Human soluble notch receptor ligands
EP1692175A4 (fr) * 2003-11-12 2008-09-17 Univ Colorado Regents Compositions et procedes de regulation du facteur-alpha de necrose tumorale
WO2005090564A1 (fr) * 2004-03-19 2005-09-29 Genomidea Inc. Gene activant le developpement de cellules endotheliales vasculaires
WO2005113773A1 (fr) * 2004-05-20 2005-12-01 Warnex Research Inc. Polynucleotides servant a detecter les producteurs de verotoxine escherichia coli o157:h7 et escherichia coli o157:nm
TW200744634A (en) 2006-02-21 2007-12-16 Wyeth Corp Methods of using antibodies against human IL-22
TWI417301B (zh) 2006-02-21 2013-12-01 Wyeth Corp 對抗人類介白素-２２（ｉｌ-２２）之抗體及其用途
KR20110025649A (ko) 2008-05-05 2011-03-10 노비뮨 에스 에이 항-ｉｌ-１７ａ／ｉｌ-１７ｆ 교차-반응성 항체 및 그의 사용 방법
RU2605318C2 (ru) 2009-05-05 2016-12-20 Новиммун С.А. Анти-il-17f антитела и способы их применения
WO2012026526A1 (fr) 2010-08-27 2012-03-01 国立大学法人宮崎大学 Récepteur d'hémokinine 1 et peptide dérivé d'hémokinine 1

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993002214A1 (fr) * 1991-07-17 1993-02-04 Medical Research Council Procede normalise d'amplification enzymatique de l'adn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993002214A1 (fr) * 1991-07-17 1993-02-04 Medical Research Council Procede normalise d'amplification enzymatique de l'adn

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GENE vol. 81, 1989, AMSTERDAM NL pages 295 - 306 AKOWITZ, A. & MANUELIDIS, L. 'A novel cDNA/PCR strategy for efficient cloning of small amounts of undefined RNA' *
NATURE vol. 355, 13 February 1992, LONDON GB pages 632 - 634 ADAMS, M. ET AL. 'Sequence identification of 2,375 human brain genes' *
NUCLEIC ACIDS RESEARCH vol. 18, no. 19, 11 October 1990, ARLINGTON, VIRGINIA US pages 5705 - 5711 KO, M.S.H. 'An 'equalized cDNA library' by the reassociation of short double-stranded cDNAs' cited in the application *
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA vol. 88, March 1991, WASHINGTON US pages 1943 - 1947 PATANJALI, S. ET AL. 'Construction of a uniform-abundance (normalized) cDNA library' cited in the application *
SCIENCE vol. 252, 21 June 1991, LANCASTER, PA US pages 1651 - 1656 ADAMS, M. ET AL. 'Complementary DNA sequencing: expressed sequence tags and human genome project' *

Also Published As

Publication number Publication date
WO1994001548A2 (fr) 1994-01-20
EP0587279A1 (fr) 1994-03-16
AU4512193A (en) 1994-01-31
GB9214857D0 (en) 1992-08-26

Similar Documents

Publication Publication Date Title
WO1994001548A3 (fr) Fragments d'acide nucleiques humains isoles du cerveau, des tissus surrenaux, du placenta ou de la moelle osseuse
WO1994011503A3 (fr) Facteur viii chimere
WO1999033982A3 (fr) Genes humains et produits d'expression genique i
CA2129820A1 (fr) Sequences d'adn codant pour les nouveaux facteurs de croissance et de differenciation
WO1999038972A9 (fr) Genes humains et produits ii d'expression genique
WO1999058675A3 (fr) Genes humains et produits d'expression genique v
IL112873A (en) Rapamycin-fkbp12 binding proteins, their isolation and their use
WO1999054461A3 (fr) Sequences d'acide nucleique humaines provenant d'une tumeur de l'endometre
EP1439230A3 (fr) Gène de la protéine transmembranaire humaine TMP-2
WO1999053040A3 (fr) Sequences d'acide nucleique humain provenant de tissu de tumeur ovarienne
BG101355A (en) Viral material and nucleotide fragments related to multiplesclerosis, for the diagnostics, prophylaxy and treatment of thisdisease
IL135687A0 (en) A novel human checkpoint kinase, hcds1, compositions and methods
WO1999051727A3 (fr) Sequences d'acides nucleiques humaines extraites des tissus sains d'ovaires
WO1999054353A3 (fr) Sequences d'acide nucleique humaines provenant du tissu normal de l'uterus
WO1998011234A3 (fr) Proteines kinases humaines
WO1999047655A3 (fr) Sequences d'acides nucleiques humains provenant de tissus mammaires sains
WO1999046375A3 (fr) Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques
WO2000024765A8 (fr) Antigenes de chlamydia, fragments d'adn correspondant et leurs utilisations
WO2000018916A3 (fr) Genes humains et produits d'expression genique
WO1995003333A3 (fr) Inhibiteurs de la tryptase
DE59410427D1 (en) Endothelinkonversionsenzym (ece)
WO2001000662A3 (fr) Utilisation de polypeptides fgh-8 humains comme agents neurotrophiques
CA2167630A1 (fr) Gene adn-c ou dock et proteine dock180
WO1999054446A3 (fr) Sequences d'acides nucleiques humains provenant de tissus sains du pancreas
CA2162577A1 (fr) Segments de gene vh d'immunoglobuline humaine et fragments d'adn qui en renferment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WA Withdrawal of international application
122 Ep: pct application non-entry in european phase
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA